MAPT and Alzheimer disease: CSF Aβ42/40 (CSF‐A), tau‐PET (neuroimaging‐T), and FDG–PET (neuroimaging‐N) were ranked the top three candidates in diagnosis accuracy for AD versus CN, as well as the high correlation with cognitive performances.